Total planned funding: $230,171,054
Allocations
Countries/Regions
Eswatini | $230,171,054 |
Organizational Types
Private Contractor | $56,629,521 |
University | $52,311,572 |
NGO | $42,889,410 |
Unknown | $30,128,119 |
Own Agency | $29,838,106 |
Host Country Government Agency | $9,343,459 |
FBO | $6,188,454 |
Multi-lateral Agency | $1,410,000 |
Implementing Agency | $759,600 |
Other USG Agency | $672,813 |
Program Areas
Care | $72,228,607 |
Treatment | $45,737,559 |
Prevention | $43,778,434 |
Governance and Systems | $30,495,769 |
Testing | $19,237,991 |
Management and Operations | $18,692,694 |
Budget Codes
HTXS: Treatment: Adult Treatment | $36,681,638 |
HBHC: Care: Adult Care and Support | $32,325,274 |
HKID: Care: Orphans and Vulnerable Children | $21,792,779 |
HVCT: Testing: HIV Testing and Counseling | $19,237,991 |
HVMS: Management and Operations | $18,692,694 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $17,000,302 |
OHSS: Health Systems Strengthening | $13,380,533 |
HVSI: Strategic Information | $12,219,126 |
HVTB: Care: TB/HIV | $11,881,586 |
HVOP: Sexual Prevention: Other Sexual Prevention | $8,634,762 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $8,458,419 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $7,709,951 |
PDCS: Care: Pediatric Care and Support | $6,228,968 |
HLAB: Laboratory Infrastructure | $4,896,110 |
PDTX: Treatment: Pediatric Treatment | $4,532,996 |
HTXD: Treatment: ARV Drugs | $4,522,925 |
HMBL: Biomedical Prevention: Blood Safety | $1,975,000 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$44,999,037
Countries/Regions
Pact, Inc.:
$27,885,240
Countries/Regions
Not Available:
$25,729,133
Countries/Regions
USG Aggregated Agencies:
$16,189,354
Countries/Regions